WEB SEARCH


TOP SELECTION

CONTACT US

info_demofinance@mynasdaq.it

DONATION

All profits of this web site are donated to charity 'the arsenal of peace'. VISIT THE WEBSITE

ADS

Complete financial analysis of PFIZER INC (PFE)

Name PFIZER INC
Year low 16.63
Year High 22.17
Symbol PFE
Last trade 21.20
Percentage change 0.43
Volume 41,152,104
Media Volume (3m) 46,419,500
PE Ratio 16.53
EPS 1.277
Market Cap 163000
Media fatt 67572
Trend fatt trend fatt graph for PFIZER INC
Media net income 11426
Trend net income trend net income for PFIZER INC
P / E P / E graph for PFIZER INC - 12 points 12
EPS EPS graph for PFIZER INC - 14 points 14
MARKET CAP / TOTAL REVENUE market  cap  /  total  revenue  graph for PFIZER INC - 4 points 4
TOT REV 1 / TOT REV 2 TOT REV 1 / TOT REV 2 graph for PFIZER INC - 5 points 5
NET INC 1 / NET INC 2 NET INC 1 / NET INC 2 graph for PFIZER INC - 11 points 11
MED NET INC / MED TOT REV MED NET INC / MED TOT REV graph for PFIZER INC - 11 points 11
NET INCOME / MARKET CAP NET  INCOME  /  MARKET  CAP graph for PFIZER INC - 5 points 5
TOTALREV1/TOTALREV3 totalRev1/totalRev3 graph for PFIZER INC - 4 points 4
NET INC1/NET INC3 net inc1/net inc3 graph for PFIZER INC - 9 points 9
TOT REV 2/ TOT REV 3 tot rev 2/ tot rev 3 graph for PFIZER INC - 3 points 3
NET INC 2 / NET INC 3 net inc 2 / net inc 3 graph for PFIZER INC - 8 points 8
. . graph for PFIZER INC - 0 points 0
MARKET CAP / NET TANGIBLE ASSETS MARKET CAP / NET TANGIBLE ASSETS graph for PFIZER INC - 0 points 0
MARK CAP/TOT STOCK EQ MARK CAP/TOT STOCK EQ graph for PFIZER INC - 0 points 0
MARKET CAP / TOT CURRENT ASSETS market cap / tot current assets graph for PFIZER INC - 0 points 0
TOT CURR ASSETS / TOT LIAB TOT CURR ASSETS / TOT LIAB graph for PFIZER INC - 8 points 8
. . graph for PFIZER INC - 0 points 0
SELL HOLD BUY SELL           HOLD          BUY graph for PFIZER INC - 0 points 0
SINTESE 94

GRAPHS

max price logarithm graph for PFIZER INC based on no conditions max volume linear graph for PFIZER INC based on no conditions

News

They Just Don't Get Merck! (Feb 05 - reuters) Merck's Lower Tax Rate (Feb 04 - reuters) Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral-28 and Norgestrel Birth Control Pill Recall (Feb 04 - reuters) Conditions of Growth, Economic Analysis -- Research Report on Pfizer Inc. and Boston Scientific Corporation (Feb 03 - reuters) Cancer Stem Cell Therapeutics In Focus (Feb 02 - reuters) Merck's Risky Cost Cutting Move (Feb 02 - reuters) Merck, Pfizer: Dow Midday Movers (Feb 02 - reuters) Defensive Dividend Portfolio Buy Zones Part II: Health Care (Feb 02 - reuters) They Just Don't Get Merck! (Feb 02 - reuters) Perception, Opportunity in Volatility - Research & Analysis on Vertex Pharmaceuticals Incorporated and Pfizer Inc. (Feb 02 - reuters) 5 Stock Picks From Moore Capital Management With 20% Upside (Feb 02 - reuters) Roche's Earnings Show Real Progress (Feb 02 - reuters) LPath's Form / Fill Delay Disappoints Investors: Long-Term Buying Opportunity? (Feb 02 - reuters) Lilly Alzheimer's drug an unlikely ace in the hole (Feb 02 - reuters) Birth control recall raises risk of unplanned pregnancy (Feb 02 - reuters) Pfizer Looking More And More Like A Dependable Company (Feb 01 - reuters) Uh-Oh, Pfizer Recalling Birth Control Pills (Feb 01 - reuters) Pfizer Issues Statement On Voluntary Recall (Feb 01 - reuters) Birth control pills recalled, may not prevent pregnancy (Feb 01 - reuters) Pfizer Recalls Birth Control: Hot Trends (Feb 01 - reuters) Sanofi More Undervalued Than Bristol, Pfizer (Feb 01 - reuters) Why Investors Should Be Cautious In Buying High-Dividend Paying Stocks (Feb 01 - reuters) Birth control pills recalled, may not prevent pregnancy (Feb 01 - reuters) Tuesday Options Recap (Jan 31 - reuters) Pfizer's CEO Discusses Q4 2011 Results - Earnings Call Transcript (Jan 31 - reuters) Generics take toll on Pfizer, Lilly profits (Jan 31 - reuters) Pfizer trims 2012 view, citing stronger dollar (Jan 31 - reuters) 6 Recession-Proof Dividend Stocks (Jan 31 - reuters) Use 'MAPS' To Find 5 Top Tier Companies (Jan 31 - reuters) Pfizer Reports Fourth-Quarter and Full-Year 2011 Results; Updates 2012 Financial Guidance (Jan 31 - reuters) Behind Roche's Pharmaceutical Shake Up (Jan 31 - reuters) The Whisper Number Impact: Earnings Preview For Pfizer, Broadcom, Eli Lilly And McGraw-Hill (Jan 31 - reuters) Pfizer Gets a Golf Clap (Jan 31 - reuters) Earnings Preview: Pfizer Reports Q4 Results Tuesday (Jan 30 - reuters) Will the Dogs of the Dow Beat the Market? (Jan 29 - reuters) India's Pfizer Oct-Dec net profit at 482.8 mln rupees (Jan 28 - reuters) U.S. Food And Drug Administration Approves Pfizer`s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC) (Jan 27 - reuters) FDA approves Pfizer's Inlyta for kidney cancer (Jan 27 - reuters) Earnings Preview For Pfizer Q4 2011 (Jan 27 - reuters) Has GlaxoSmithKline Become the Perfect Stock? (Jan 27 - reuters) Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph+ Chronic Myeloid Leukemia (Jan 27 - reuters) Lpath Temporarily Suspends Dosing of iSONEP in Clinical Trials Due to cGMP Compliance Issues at Contract Fill/Finish (Jan 27 - reuters) Beyond Yield: Examining 7 Dividend Stocks' Total Return Potential (Jan 27 - reuters) Merrimack IPO: Repackaging And Refining Chemotherapy (Jan 26 - reuters) Trius Therapeutics: Outstanding Potential, Discount Price (Jan 26 - reuters) Alzheimer's Challenge 2012: Seeking New Tools to Help Improve Alzheimer's Care (Jan 26 - reuters) Alzheimer's Challenge 2012: Seeking New Tools To Help Improve Alzheimer`s Care (Jan 26 - reuters) Verastem IPO Looks Like Risky Bet (Jan 26 - reuters) IPO: Unproven Verastem (Jan 26 - reuters) IPO Preview: Verastem (Jan 25 - reuters)

ADS

MY PORTFOLIO



GAIN vs LOSS


BEST vs WORST


SELECTION DIY

Market Cap
Last Trade
Gain/Loss
Webtech:
P / E
EPS
market cap / total revenue
TOT REV 1 / TOT REV 2
NET INC 1 / NET INC 2
MED NET INC / MED TOT REV
NET INCOME / MARKET CAP
totalRev1/totalRev3
net inc1/net inc3
tot rev 2/ tot rev 3
net inc 2 / net inc 3
.
MARKET CAP / NET TANGIBLE ASSETS
MARK CAP/TOT STOCK EQ
market cap / tot current assets
TOT CURR ASSETS / TOT LIAB
.
SELL HOLD BUY